Renalytix AI Plc Share Price

Renalytix AI Plc competes in the Health Care and Social Assistance sector and Diagnostic Imaging Centers industry. It is headquartered in Penarth, United Kingdom and is traded on the London Stock Exchange, through the symbol RENX-LN.

Previous Close:
GBX£0.18 0% (December 5th, 2023)

Latest Share Trading Activity for Renalytix AI Plc

Day Open:
GBX£16.10(previous open GBX£0.18)
Day High:
GBX£17.40(previous high GBX£0.18)
Day Low:
GBX£15.00(previous low GBX£0.18)

About Renalytix AI Plc

Company Description
renalytix ai plc (lse aim: renx) is a leading developer of artificial intelligence-enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. the company’s solutions are being designed to make significant improvements in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. renalytixai’s initial diagnostic product, kidneyintelx™, is designed to diagnose and improve clinical management of patients with type ii diabetes and those of african ancestry with fast-progressing kidney disease in an effort to curtail the estimated $114 billion cost of chronic and end-stage kidney disease to the u.s. healthcare system. renalytixai expects to commercially launch kidneyintelx as a laboratory developed test in its clia laboratory facilities to health systems and drug developers in h2 2019. the company also intends to submit kidneyintelx for regulatory rev
Chief Executive Officer (CEO)
Postal Address
Avon HSE 19 Stanwell Road South Glamorgan Penarth United Kingdom
Phone Number

Renalytix AI Plc Historic Prices and Volume

Issue CountryGB
52 Week Range£0.17 - £1.50
52 Week Change-£0.80
50 Day Moving Average£0.34
200 Day Moving Average£0.79
Average 10 Day Volume49276
Average 30 Day Volume78166
5 Day % Change-20%
30 Day % Change-57%
3 Month % Change-84%
6 Month % Change-79%
1 Year % Change-79%
2 Year % Change-97%
5 Year % Change-83%
Year To Date % Change-75%

© 2023

While does what we can to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.